2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The …

SV Konstantinides, G Meyer, C Becattini… - European heart …, 2020‏ - academic.oup.com
determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …

Venoarterial ECMO for Adults: JACC Scientific Expert Panel

M Guglin, MJ Zucker, VM Bazan, B Bozkurt… - Journal of the American …, 2019‏ - jacc.org
Venoarterial extracorporeal membrane oxygenation (ECMO) is a rescue therapy that can
stabilize patients with hemodynamic compromise, with or without respiratory failure, for days …

Diagnosis, treatment and follow up of acute pulmonary embolism: consensus practice from the PERT consortium

B Rivera-Lebron, M McDaniel, K Ahrar… - Clinical and Applied …, 2019‏ - journals.sagepub.com
Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity
and mortality. There have been many advances in the field of PE in the last few years …

The international society for heart and lung transplantation/heart failure society of America guideline on acute mechanical circulatory support

AM Bernhardt, H Copeland, A Deswal… - The Journal of Heart …, 2023‏ - jhltonline.org
See page 49 for disclosure information. List of abbreviations: ACT, activated clotting time;
aPTT, activated partial thromboplastin time; ACHD, adult congenital heart disease; ADHF …

Extracorporeal membrane oxygenation for cardiogenic shock: a meta-analysis of mortality and complications

S Rajsic, B Treml, D Jadzic, R Breitkopf… - Annals of intensive …, 2022‏ - Springer
Background Venoarterial extracorporeal membrane oxygenation (va-ECMO) is an advanced
life support for critically ill patients with refractory cardiogenic shock. This temporary support …

Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in …

M Shah, S Patnaik, B Patel, P Ram, L Garg… - Clinical Research in …, 2018‏ - Springer
Background Recent trends on outcomes in cardiogenic shock (CS) complicating acute
myocardial infarction (AMI) suggest improvements in early survival. However, with the ever …

Simultaneous venoarterial extracorporeal membrane oxygenation and percutaneous left ventricular decompression therapy with Impella is associated with improved …

SM Patel, J Lipinski, SG Al-Kindi, T Patel, P Saric… - ASAIO …, 2019‏ - journals.lww.com
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been used for
refractory cardiogenic shock; however, it is associated with increased left ventricular …

Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use

Z Papp, P Agostoni, J Alvarez, D Bettex… - Journal of …, 2020‏ - journals.lww.com
Levosimendan was first approved for clinical use in 2000, when authorization was granted
by Swedish regulatory authorities for the hemodynamic stabilization of patients with acutely …

Parameters associated with successful weaning of veno-arterial extracorporeal membrane oxygenation: a systematic review

F Charbonneau, K Chahinian, E Bebawi, O Lavigueur… - Critical Care, 2022‏ - Springer
Purpose Veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) can be used to
restore organ perfusion in patients with cardiogenic shock until native heart recovery occurs …

Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: a …

E Sy, MC Sklar, L Lequier, E Fan, HD Kanji - Journal of critical care, 2017‏ - Elsevier
Purpose The purpose was to evaluate the safety of anticoagulation in venoarterial
extracorporeal membrane oxygenation (VA-ECMO). Design We performed a systematic …